Receive Promise magazine online to learn about the innovative research and excellent medical care happening at St. Jude. Your free subscription will start with our next quarterly issue of Promise.
In this issue . . .
Medulloblastoma: The Pieces Snap Together
St. Jude scientists discover genes suspected to cause brain tumors in children. This discovery lays the foundation to expand targeted treatments.
Six More Reasons to Love St. Jude
Patients and families often praise St. Jude clinical care and research. Find out why they have even more reasons to love the hospital.
Keeping Flu at Bay
At Delaware Bay, scientists gather crucial influenza data for research and vaccine development.
A Referral Clinic for Rare Endocrine Cancers
St. Jude creates a national referral clinic to advance cures for rare cancers of the endocrine system.
Investing in the Kids
Stocks may rise and fall, but a long-term investment in the lives of children always pays dividends.
St. Jude in China
St. Jude continues its 25-year quest to raise the survival rate of childhood cancer for kids in China. Find out partnerships are making this possible.
Opening Doors to the Future
St. Jude partner Brooks Brothers has raised more than $16 million. Read about how this doorman does his part to contribute.
Donors and Volunteers: The Lifeblood of St. Jude
Read a heartfelt thank you letter from Richard C. Shadyac, ALSAC president and CEO, to all St. Jude supporters and volunteers.
A surprise proposal occurs in the hospital where one patient got a new chance at life.
Research Highlights - Promise Autumn 2017
Read about advancements in HPV and RSV vaccines, T cell receptors, heme synthesis, the Childhood Solid Tumor Network, and more.